Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Erhardt, L.R.
Right arrow Articles by Betteridge, D.J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Erhardt, L.R.
Right arrow Articles by Betteridge, D.J.

The European Society of Cardiology
L.R. Erhardta,* and D.J. Betteridgeb

a Department of Cardiology, Malmö University Hospital, 205 02 Malmö, Sweden
b Department of Medicine, University College London Medical School, London, UK

* Correspondence: Dr. L.R. Erhardt, Department of Cardiology, Malmö University Hospital, 205 02 Malmö, Sweden. Tel.: +46 40 33 1941; fax: +46 40 33 7329 (E-mail: leif.erhardt@medforsk.mas.lu.se).

The first 10% of the full text of this article appears below.

Introduction

Cardiovascular disease (CVD) involves a complex interplay of risk factors, many of which share common pathogenic mechanisms. Risk factors, such as dyslipidaemia, hypertension, hyperglycaemia and diabetes, tend to cluster in individuals, and have a synergistic effect on CVD risk. For example, risk is greater in patients with diabetes compared with patients without diabetes. As a result, the National Cholesterol Education Program . . . [Full Text of this Article]